Unlock the Benefits of the Australian Government R&D Tax Incentive

For every $1.00 spent, up to $0.435 may potentially be be returned.

Clinical Trials

Speed

Australia has a favourable regulatory environment for early phase studies. An IND is not required, and studies with healthy volunteers take only 4-6 weeks for review and approval.

Quality

ICH guidelines are followed in all Australian clinical trials, meaning that the data is generally accepted by global regulatory bodies.

Facilities

There are many high quality Phase 1 and hospital-based state-of-the-art units with a long history of successful FDA (and other regulatory bodies) inspections.

Advantages

• High probability of obtaining regulatory approval for conducting studies in heathy volunteers
• Australia has a diverse population lending itself to diversity in clinical trials
• It is possible to submit an IND for review and complete a Phase 1 clinical trial in Australia during the IND review process.